Pharma in Brief

AUGUST 9, 2021

On July 31, 2021, Health Canada published a Notice of Intent outlining its plan to amend the Food and Drug Regulations ( FDR ) and the Medical Devices Regulations in the spring of 2022. The amendments contemplate labelling flexibilities for special containers. Food and Drug Regulations , C.R.C., On-site Evaluations.

Regulation 98

Regulation Drugs Manufacturing Production 98

XTalks

FEBRUARY 8, 2024

In its 2022 financial report, Sanofi reported that sales of the long-acting insulin dropped 27.6 percent in the US, impacted by prior formulary losses as well as “erosion of the basal insulin market,” the company said in the statement. In its 2022 financial report, Sanofi reported that sales of the long-acting insulin dropped 27.6

Sales 52

Sales Insulin FDA Approval Drugs 52

The Pharma Data

MAY 15, 2021

One French scientists concluded that this ingredient contains something which stimulates the growth of cancerous tumors! Page 51 – 75 percent of all adverse reactions from all food additives reported to the FDA are due to this one common food additive found in most pre-packaged foods.

Doctors 52

Doctors Doctor Containment Allergies 52

The Pharma Data

MAY 14, 2021

It may also improve your sensitivity to insulin, which means it works better in your body. Talk to your doctor about whether you need to adjust your meds or insulin dose to keep your levels high enough. When you drink, the liver has to work to remove the alcohol from the blood instead of regulating blood sugar.

Production 52

Production Packaging Packaging Insulin 52

The Pharma Data

AUGUST 3, 2021

The company confirmed the tirzepatide SURPASS program has met global regulatory submission requirements for evaluating cardiovascular risk and its intention to submit the registration package to regulatory authorities by the end of 2021. 25% $ 2,988.1 $ 2,459.1 22% Humalog ®(a) 607.6 2)% Alimta 610.6 6% Taltz 569.1 26% Humulin ® 315.3

Antibody 52

Antibody Sales Development Production 52

XTalks

AUGUST 2, 2023

2) Paxlovid (nirmatrelvir/ritonavir) Paxlovid is a dual-packaged oral medication for the treatment of COVID-19. It contains the antiviral medications nirmatrelvir and ritonavir. In September 2022, Roche acquired Good Therapeutics for an upfront payment of $250 million, and has access to their PD-1-regulated IL-2 program.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

MAY 13, 2021

FACT: A recent study conducted by the Grocery Manufacturer’s Association states that OVER 80% of packaged foods eaten in the U.S. FACT: Food labels are NOT required to fully disclose the amounts of certain ingredients contained within foods you consume. These ingredients can be harmful and even LIFE THREATENING. Around 60% of the U.S.

Production 52

Production Containment Genetics Doctors 52